News

The U.S. Food and Drug Administration today confirmed that IQOS 3, Philip Morris International’ s electrically heated tobacco system, is appropriate for the protection of public health and has ...
Philip Morris International Announces U.S. Food and Drug Administration Authorization For Sale of IQOS in the United States April 30, 2019 02:20 PM Eastern Daylight Time ...
The Food and Drug Administration said it would allow two of the world’s biggest cigarette makers to start selling in the U.S. a hand-held device that heats but doesn’t burn tobacco.
The Food and Drug Administration cleared Philip Morris International’s IQOS — a heat-not-burn tobacco device designed as an alternative to conventional cigarettes — for sale in the United ...
Earlier this month, the Food and Drug Administration authorized 20 Zyn products to be marketed and sold in the U.S. The FDA had allowed Zyn to be sold legally in the U.S. while the agency reviewed ...
Although the Food and Drug Administration has authorized the commercialization of Philip Morris’ IQOS electronic device and is allowing it to be marketed as “a modified risk tobacco product ...
Philip Morris International Inc. on October 20 ... Applications and Modified Risk Tobacco Product Applications for IQOS ILUMA heated tobacco products with the U.S. Food and Drug Administration.
A pioneer in modified risk products, Swedish Match was the first company to receive a modified risk marketing claim and is the first to advance through the FDA renewal process Swedish Match ...
Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage ...
Philip Morris International has been on a buying spree of ... IQOS became the first vaping product authorized by the Food and Drug Administration to be marketed as reducing exposure to harmful ...
Philip Morris International has announced a $232 million factory expansion in Kentucky. ... The Food and Drug Administration says no tobacco product is safe.
Philip Morris International ... and Philip Morris found enough support for its claims to form the foundation of its application to the U.S. Food and Drug Administration for IQOS as a modified ...